The U.S. Food and Drug Administration (FDA) has named Cala Trio a breakthrough device as a potential wrist-worn treatment of action tremors in the hands of adults with Parkinson’s disease. ... Read more
Parkinson’s Disease Remission: Can the Conductor Help?In previous columns, I have discussed using the conductor (in particular, the resting mind state) to suppress faulty input from the second dopamine center, thus ... Read more
Sanofi Supports PD GENEration Initiative to Increase Genetic Testing of Parkinson’s PatientsSanofi will provide $1 million in research funding over the next two years to support PD GENEration, a national initiative seeking to increase the ... Read more
Phase 2b Trial of Prasinezumab in Patients With Early Parkinson’s Expected by 2021Roche, in partnership with Prothena, will launch a Phase 2b clinical trial to evaluate the effectiveness of prasinezumab (PRX002/RG7935) — an antibody against the alpha-synuclein protein — in ... Read more
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
A new tool called cardiopulmonary coupling could be used to effectively evaluate sleep quality in Parkinson’s disease patients, who often experience sleep disorders, according to a study. The study, “Assessment of sleep quality using cardiopulmonary coupling analysis in patients with ... Read more